Heyu Biological Technology Corp | Business Contracts

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 23, 2023)

Clinical Cooperation Agreement entered into and by Jiashierle (Xiamen) Healthcare Technology Co., Ltd. and Shenzhen Saikun Biotechnology Co., Ltd., dated October 15, 2019 (Filed With SEC on November 14, 2019)

Share Cancellation Agreement with Ban Siong Ang dated March 15, 2019 (Filed With SEC on March 21, 2019)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 15, 2022)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 1, 2022)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2020)

Director Offer Letter for a Director with Mr. Busch dated April 16, 2019 (Filed With SEC on July 10, 2019)

Director Offer Letter for an Independent Director with Mr. Busatlic dated April 16, 2019 (Filed With SEC on July 10, 2019)

Director Offer Letter for a Director with Mr. Busch dated April 16, 2019 (Filed With SEC on July 1, 2019)

Director Offer Letter for an Independent Director with Mr. Busatlic dated April 16, 2019 (Filed With SEC on July 1, 2019)

Heyu Biological Technology Corp (10)